RSLBF (RaySearch Laboratories AB) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RSLBF RaySearch Laboratories AB RSLBF
90 GF Score
Price $18.85
GF Value $20.98
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB SpecialCharges?

Special Charges only applies to banks.

RSLBF
90GF Score
RaySearch Laboratories AB RSLBF
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is RaySearch Laboratories AB (RSLBF) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be undervalued. The current stock price of $18.85 is trading 10.2% below its estimated GF Value™ of $20.98. GuruFocus considers RaySearch Laboratories AB to be Modestly Undervalued.

Key valuation signals for RSLBF:

  • SpecialCharges:
  • GF Value™: $20.98 vs. price of $18.85 (10.2% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the RSLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
90GF Score

Get the complete analysis for RSLBF

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.85
Price
$20.98
GF Value